WeWork India Management Employee Stock Options

WeWork India Management Earnings Call Transcript: Key Takeaways

WeWork India delivered strong operational scale with record capacity additions and 31.6% YoY revenue growth. Management emphasizes structural margin expansion despite heavy front-loaded capex for large managed office deals.

WeWork India Management Business Update

WeWork India Management approved an amended Code of Practices for Fair Disclosure of UPSI on 26 October 2026. The revised code is published on the company website.

WeWork India Management Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹768.7 Cr (+31.6% YoY), EBITDA ₹162.9 Cr (21.2% margin), PAT ₹65.8 Cr (+67.4% YoY). Net cash ₹23.1 Cr; flex-led branded expansion continues.

WeWork India Management Results Update

WeWork India released Q2 FY27 results highlighting strong revenue, EBITDA and PAT growth. The company also reported record desk additions and improved cash generation.

WeWork India Management Q2 FY27 Results: Net Profit ₹20.4 Cr, Up 218.7% YoY

WeWork India Management Ltd reported revenue from operations of ₹767.8 Cr (+33.6% YoY) and net profit of ₹20.4 Cr (+218.7% YoY) for Q2 FY27.

Key figure

Net profit ₹20.4 Cr · +218.7% YoY

WeWork India Management Other Announcement

WeWork India Management Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI regulations.

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Maxvolt Energy Industries Employee Stock Options

Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.

Execution

Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date